FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317522926> ?p ?o ?g. }

• W4317522926 endingPage "e43675" @default.
• W4317522926 startingPage "e43675" @default.
• W4317522926 abstract "Even modest reductions in blood pressure (BP) can have an important impact on population-level morbidity and mortality from cardiovascular disease. There are 2 promising approaches: the SaltSwitch smartphone app, which enables users to scan the bar code of a packaged food using their smartphone camera and receive an immediate, interpretive traffic light nutrition label on-screen alongside a list of healthier, lower-salt options in the same food category; and reduced-sodium salts (RSSs), which are an alternative to regular table salt that are lower in sodium and higher in potassium but have a similar mouthfeel, taste, and flavor.Our aim was to determine whether a 12-week intervention with a sodium-reduction package comprising the SaltSwitch smartphone app and an RSS could reduce urinary sodium excretion in adults with high BP.A 2-arm parallel randomized controlled trial was conducted in New Zealand (target n=326). Following a 2-week baseline period, adults who owned a smartphone and had high BP (≥140/85 mm Hg) were randomized in a 1:1 ratio to the intervention (SaltSwitch smartphone app + RSS) or control (generic heart-healthy eating information from The Heart Foundation of New Zealand). The primary outcome was 24-hour urinary sodium excretion at 12 weeks estimated via spot urine. Secondary outcomes were urinary potassium excretion, BP, sodium content of food purchases, and intervention use and acceptability. Intervention effects were assessed blinded using intention-to-treat analyses with generalized linear regression adjusting for baseline outcome measures, age, and ethnicity.A total of 168 adults were randomized (n=84, 50% per group) between June 2019 and February 2020. Challenges associated with the COVID-19 pandemic and smartphone technology detrimentally affected recruitment. The adjusted mean difference between groups was 547 (95% CI -331 to 1424) mg for estimated 24-hour urinary sodium excretion, 132 (95% CI -1083 to 1347) mg for urinary potassium excretion, -0.66 (95% CI -3.48 to 2.16) mm Hg for systolic BP, and 73 (95% CI -21 to 168) mg per 100 g for the sodium content of food purchases. Most intervention participants reported using the SaltSwitch app (48/64, 75%) and RSS (60/64, 94%). SaltSwitch was used on 6 shopping occasions, and approximately 1/2 tsp per week of RSS was consumed per household during the intervention.In this randomized controlled trial of a salt-reduction package, we found no evidence that dietary sodium intake was reduced in adults with high BP. These negative findings may be owing to lower-than-anticipated engagement with the trial intervention package. However, implementation and COVID-19-related challenges meant that the trial was underpowered, and it is possible that a real effect may have been missed.Australian New Zealand Clinical Trials Registry ACTRN12619000352101; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377044 and Universal Trial U1111-1225-4471." @default.
• W4317522926 created "2023-01-20" @default.
• W4317522926 creator A5008452845 @default.
• W4317522926 creator A5015704931 @default.
• W4317522926 creator A5046411535 @default.
• W4317522926 creator A5049757171 @default.
• W4317522926 creator A5061367285 @default.
• W4317522926 creator A5074062324 @default.
• W4317522926 creator A5075162144 @default.
• W4317522926 creator A5086671233 @default.
• W4317522926 creator A5087480968 @default.
• W4317522926 creator A5088739718 @default.
• W4317522926 date "2023-03-09" @default.
• W4317522926 modified "2023-10-04" @default.
• W4317522926 title "Effectiveness of a Sodium-Reduction Smartphone App and Reduced-Sodium Salt to Lower Sodium Intake in Adults With Hypertension: Findings From the Salt Alternatives Randomized Controlled Trial" @default.
• W4317522926 cites W1481480932 @default.
• W4317522926 cites W2008203632 @default.
• W4317522926 cites W2108696783 @default.
• W4317522926 cites W2152967809 @default.
• W4317522926 cites W2157171980 @default.
• W4317522926 cites W2654137919 @default.
• W4317522926 cites W2781714002 @default.
• W4317522926 cites W2785273501 @default.
• W4317522926 cites W2801689995 @default.
• W4317522926 cites W2894724600 @default.
• W4317522926 cites W2902390101 @default.
• W4317522926 cites W2907615587 @default.
• W4317522926 cites W2919440236 @default.
• W4317522926 cites W2944434778 @default.
• W4317522926 cites W2973566804 @default.
• W4317522926 cites W3000584627 @default.
• W4317522926 cites W3005813910 @default.
• W4317522926 cites W3008205394 @default.
• W4317522926 cites W3043620318 @default.
• W4317522926 cites W3118736010 @default.
• W4317522926 cites W3135591989 @default.
• W4317522926 cites W3143437408 @default.
• W4317522926 cites W3206054276 @default.
• W4317522926 cites W4207082632 @default.
• W4317522926 cites W4221038410 @default.
• W4317522926 cites W4236805817 @default.
• W4317522926 cites W4284700580 @default.
• W4317522926 cites W4291020115 @default.
• W4317522926 cites W4292115103 @default.
• W4317522926 doi "https://doi.org/10.2196/43675" @default.
• W4317522926 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36892914" @default.
• W4317522926 hasPublicationYear "2023" @default.
• W4317522926 type Work @default.
• W4317522926 citedByCount "2" @default.
• W4317522926 countsByYear W43175229262023 @default.
• W4317522926 crossrefType "journal-article" @default.
• W4317522926 hasAuthorship W4317522926A5008452845 @default.
• W4317522926 hasAuthorship W4317522926A5015704931 @default.
• W4317522926 hasAuthorship W4317522926A5046411535 @default.
• W4317522926 hasAuthorship W4317522926A5049757171 @default.
• W4317522926 hasAuthorship W4317522926A5061367285 @default.
• W4317522926 hasAuthorship W4317522926A5074062324 @default.
• W4317522926 hasAuthorship W4317522926A5075162144 @default.
• W4317522926 hasAuthorship W4317522926A5086671233 @default.
• W4317522926 hasAuthorship W4317522926A5087480968 @default.
• W4317522926 hasAuthorship W4317522926A5088739718 @default.
• W4317522926 hasBestOaLocation W43175229261 @default.
• W4317522926 hasConcept C126322002 @default.
• W4317522926 hasConcept C168563851 @default.
• W4317522926 hasConcept C178790620 @default.
• W4317522926 hasConcept C185592680 @default.
• W4317522926 hasConcept C1862650 @default.
• W4317522926 hasConcept C2780018836 @default.
• W4317522926 hasConcept C2908647359 @default.
• W4317522926 hasConcept C537181965 @default.
• W4317522926 hasConcept C71924100 @default.
• W4317522926 hasConcept C84393581 @default.
• W4317522926 hasConcept C99454951 @default.
• W4317522926 hasConceptScore W4317522926C126322002 @default.
• W4317522926 hasConceptScore W4317522926C168563851 @default.
• W4317522926 hasConceptScore W4317522926C178790620 @default.
• W4317522926 hasConceptScore W4317522926C185592680 @default.
• W4317522926 hasConceptScore W4317522926C1862650 @default.
• W4317522926 hasConceptScore W4317522926C2780018836 @default.
• W4317522926 hasConceptScore W4317522926C2908647359 @default.
• W4317522926 hasConceptScore W4317522926C537181965 @default.
• W4317522926 hasConceptScore W4317522926C71924100 @default.
• W4317522926 hasConceptScore W4317522926C84393581 @default.
• W4317522926 hasConceptScore W4317522926C99454951 @default.
• W4317522926 hasLocation W43175229261 @default.
• W4317522926 hasLocation W43175229262 @default.
• W4317522926 hasLocation W43175229263 @default.
• W4317522926 hasOpenAccess W4317522926 @default.
• W4317522926 hasPrimaryLocation W43175229261 @default.
• W4317522926 hasRelatedWork W1950397665 @default.
• W4317522926 hasRelatedWork W1996644791 @default.
• W4317522926 hasRelatedWork W2365129915 @default.
• W4317522926 hasRelatedWork W3028716580 @default.
• W4317522926 hasRelatedWork W3159250744 @default.
• W4317522926 hasRelatedWork W4256514411 @default.
• W4317522926 hasRelatedWork W4292236216 @default.
• W4317522926 hasRelatedWork W4292296623 @default.
• W4317522926 hasRelatedWork W56368578 @default.

• next